Position in CLDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,329,399
+$428,748 QoQ
Shares Held
196,974
-9.5% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 252 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,792 across 523 Biotechnology names. CLDX ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CLDX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,329,399 | 196,974 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,900,651 | 217,549 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,755,127 | 285,535 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $8,069,340 | 311,919 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $13,461,887 | 661,518 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $16,387,304 | 902,882 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $33,965,378 | 1,344,099 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $14,813,449 | 435,818 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $6,069,339 | 163,992 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $15,785,794 | 376,121 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $26,110,751 | 658,365 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $14,412,221 | 523,700 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $4,675,007 | 137,784 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,739,754 | 493,045 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,078,415 | 203,689 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,717,091 | 203,383 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,995,444 | 482,027 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $34,707,954 | 1,019,024 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $11,821,248 | 305,933 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,585,164 | 177,536 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,118,434 | 123,159 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $453,302 | 22,005 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $342,445 | 19,546 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $235,484 | 15,879 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $300,846 | 23,142 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $32,374 | 19,503 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||